Chenxi Wu
Impact in
- Drug Discovery top 10%
- Immunology top 10%
- Immunotherapy and Immune Responses
Papers in
- Aging 3
- Immunology 13
- Immunotherapy and Immune Responses 4
- Co-authors
- Tianmeng SunYong‐Guang YangHongmei ChenJialiang WangKuirong MaoXiuxiu CongXiaohong ChenLiang Cheng
- Journals
- Biomaterials Science (4 papers)Journal of Ethnopharmacology (3 papers)Open Biology (3 papers)Proceedings of the National Academy of Sciences (3 papers)Cell Death and Disease (3 papers)
- Partner nations
- ChinaUnited StatesCroatia
In The Last Decade
Chenxi Wu
55 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 109
- Drug Discovery 2
- Immunology 240
- Aging 19
- Cancer Research 162
- Biomaterials 134
Countries citing papers authored by Chenxi Wu
This map shows the geographic impact of Chenxi Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenxi Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenxi Wu more than expected).
Fields of papers citing papers by Chenxi Wu
This network shows the impact of papers produced by Chenxi Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenxi Wu. The network helps show where Chenxi Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chenxi Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 4 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 63 | |
| 8 | 2023 | 46 | |
| 9 | 2023 | 17 | |
| 10 | 2023 | 8 | |
| 11 | 2022 | 5 | |
| 12 | 2022 | 5 | |
| 13 | 2022 | 16 | |
| 14 | 2022 | 18 | |
| 15 | 2021 | 25 | |
| 16 | 2020 | 70 | |
| 17 | 2017 | 13 | |
| 18 | 2015 | 20 | |
| 19 | 2014 | 136 | |
| 20 | 2011 | 90 |
About Chenxi Wu
Chenxi Wu is a scholar working on Aging, Immunology, Cancer Research, Molecular Biology and Cell Biology, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (8 papers), Nanoplatforms for cancer theranostics (7 papers), Wnt/β-catenin signaling in development and cancer (5 papers), Neurobiology and Insect Physiology Research (4 papers), FOXO transcription factor regulation (4 papers), Immunotherapy and Immune Responses (4 papers), Ubiquitin and proteasome pathways (4 papers) and Extracellular vesicles in disease (4 papers). The work is most often cited by research in Drug Discovery (2 citations), Immunology (240 citations), Aging (19 citations), Cancer Research (162 citations) and Biomaterials (134 citations). Chenxi Wu has collaborated with scholars based in China, United States and Croatia. Frequent co-authors include Tianmeng Sun, Yong‐Guang Yang, Hongmei Chen, Jialiang Wang, Kuirong Mao, Xiuxiu Cong, Xiaohong Chen, Liang Cheng, Gang Niu and Xiaolian Sun. Their work appears in journals such as Biomaterials Science, Journal of Ethnopharmacology, Open Biology, Proceedings of the National Academy of Sciences and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.